Hammer Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Hammer Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$436K	Sell	7,036 -221	-3%	-$13.6K	2.11%	27
2020 Q3	$438K	Sell	7,257 -4,290	-37%	-$258K	1.95%	30
2020 Q2	$679K	Sell	11,547 -813	-7%	-$48.6K	1.94%	28
2020 Q1	$689K	Sell	12,360 -28,798	-70%	-$1.76M	2.17%	19
2019 Q4	$2.64M	Buy	41,158 +7	+0%	+$401	1.99%	24
2019 Q3	$2.09M	Buy	41,151 +444	+1%	+$20.9K	1.66%	31
2019 Q2	$1.85M	Buy	40,707 +9	+0%	+$419	1.52%	37
2019 Q1	$1.94M	Buy	40,698 +3,525	+9%	+$176K	1.72%	30
2018 Q4	$1.93M	Sell	37,173 -6,271	-14%	-$337K	1.89%	24
2018 Q3	$2.7M	Sell	43,444 -183	-0.4%	-$10.9K	2.21%	25
2018 Q2	$2.41M	Buy	+43,627	New	+$2.36M	2.11%	27

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hammer Asset Management's BMY Position: Q4 2020 in Review

Hammer Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 3% in Q4 2020, selling an estimated $13.6K and leaving 7,036 shares worth $436K. The position accounts for 2.11% of the portfolio, ranked #27.

Hammer Asset Management first reported a position in BMY in Q2 2018 and has held it in 11 quarters since. The position peaked at $2.7M in Q3 2018. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Hammer Asset Management held 7,036 shares of Bristol-Myers Squibb worth $436K as of Q4 2020.
Hammer Asset Management sold 221 Bristol-Myers Squibb shares in Q4 2020, an estimated $13.6K.
Bristol-Myers Squibb made up 2.11% of Hammer Asset Management's portfolio in Q4 2020, its #27 holding.
Hammer Asset Management first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 11 quarters since.
Hammer Asset Management's Bristol-Myers Squibb position peaked at $2.7M in Q3 2018.
2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Hammer Asset Management's 13F filing for Q4 2020, filed 19 Jan 2021.